Stay updated on Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T13:58:19.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to include new details about a clinical trial for Nadunolimab in combination with chemotherapy for advanced Triple Negative Breast Cancer, including the study's interventional model and collaborators. Notably, extensive background information on Triple Negative Breast Cancer has been removed.
    Difference
    51%
    Check dated 2025-04-16T02:09:33.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 14, 2025.
    Difference
    0.1%
    Check dated 2025-04-08T23:53:18.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 14, 2025, and version 2.14.2.
    Difference
    0.1%
    Check dated 2025-04-01T19:02:01.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The study is now marked as 'Active, not recruiting' and has updated its number of locations from 24 to 23. Additionally, the study dates have been revised to reflect new timelines.
    Difference
    1%
    Check dated 2025-03-18T04:54:37.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.5%
    Check dated 2025-03-03T22:26:10.000Z thumbnail image

Stay in the know with updates to Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page.